Commentary Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/cardiology.2.012
Cardiac Stem Cell Therapy, Quo Vadis
Daniel Alexander Hescheler1, Hescheler Jürgen2,*
- 1Department of Nuclear Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany
- 2Institute of Neurophysiology, University of Cologne, Robert-Koch Str. 39, 50931 Cologne, Germany
Corresponding Author
Hescheler Jürgen, J.Hescheler@uni-koeln.de
Received Date: May 08, 2021
Accepted Date: May 25, 2021
Daniel H, Jürgen H. Cardiac Stem Cell Therapy, Quo Vadis. J Clin Cardiol. 2021; 2(2):27-29.
Copyright: © 2021 Daniel H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Cardiac Stem Cell Therapy, Quo Vadis
Cardiovascular disease causes 30% of global mortality and is still the number one cause of death worldwide. A main patho-physiological process is the coronary disease leading to malperfusion and ischemic cardiac disease as well as cardiac infarction.
Lenalidomide Maintenance After Autologous Stem Cell Transplant: The Utility of Real-World Data and Future Areas of Study
Low-dose, lenalidomide maintenance following autologous stem cell transplantation (ASCT) is the current standard of care in patients with newly diagnosed multiple myeloma (NDMM) based on results from large, randomized controlled trials and a meta-analysis which demonstrated improved overall (OS) and progressionfree survival (PFS).
Quantifying Neural Stem Cell-Derived Extracellular Vesicle Uptake Using Imaging Flow Cytometry
Nanomedicine, which includes nanoparticles and other nanomaterials for diagnosis and therapeutic delivery to treat numerous diseases, is making advances.
News About the Extracellular Vesicles from Mesenchymal Stem Cells: Functions, Therapy and Protection from COVID-19
The present Commentary is a critical follow-up of a previous review about “Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases”, appeared in Clinical and Experimental Immunology last June 2019 [1].
Targeting the Cancer Stem Cell (CSC) Phenotype: Uprooting the Evil Seed
If cancer is considered the emperor of all maladies, then it is fair to say that cancer stem cells (CSCs) are the seeds that spread this evil.